DMAS.JK(DMAS.JK)
DMAS.JK
No analyst ratings available
No analyst price targets available for DMAS.JK
Analyst coverage may not be available for this symbol
Earnings surprise history unavailable.
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $1.45T | $1.53T | $2.04T |
| Low | $1.45T | $1.53T | $2.04T |
| High | $1.45T | $1.53T | $2.04T |
| EBITDA Avg | $895.87B | $944.41B | $1.26T |
| Low | $895.87B | $944.41B | $1.26T |
| High | $895.87B | $944.41B | $1.26T |
| EBIT Avg | $865.17B | $912.05B | $1.22T |
| Low | $865.17B | $912.05B | $1.22T |
| High | $865.17B | $912.05B | $1.22T |
| Net Income Avg | $1.00T | $1.08T | $1.38T |
| Low | $1.00T | $1.08T | $1.38T |
| High | $1.00T | $1.08T | $1.38T |
| EPS Avg | $20.81 | $22.51 | $28.65 |
| Low | $20.81 | $22.51 | $28.65 |
| High | $20.81 | $22.51 | $28.65 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q2 2028 | Q3 2028 | Q4 2028 | Q1 2029 | Q3 2029 | Q4 2029 |
|---|---|---|---|---|---|---|
| Revenue Avg | $745.00B | $745.00B | $938.00B | $938.00B | $343.00B | $343.00B |
| Low | $745.00B | $745.00B | $938.00B | $938.00B | $343.00B | $343.00B |
| High | $745.00B | $745.00B | $938.00B | $938.00B | $343.00B | $343.00B |
| EBITDA Avg | $461.35B | $461.35B | $580.87B | $580.87B | $212.41B | $212.41B |
| Low | $461.35B | $461.35B | $580.87B | $580.87B | $212.41B | $212.41B |
| High | $461.35B | $461.35B | $580.87B | $580.87B | $212.41B | $212.41B |
| EBIT Avg | $445.54B | $445.54B | $560.97B | $560.97B | $205.13B | $205.13B |
| Low | $445.54B | $445.54B | $560.97B | $560.97B | $205.13B | $205.13B |
| High | $445.54B | $445.54B | $560.97B | $560.97B | $205.13B | $205.13B |
| Net Income Avg | — | — | — | — | — | — |
| Low | — | — | — | — | — | — |
| High | — | — | — | — | — | — |
| EPS Avg | — | — | — | — | — | — |
| Low | — | — | — | — | — | — |
| High | — | — | — | — | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — | 1 / — | 1 / — | 1 / — |